The top early Nest, Arlo, Ring, Blink & Philips Hue deals for Amazon Prime Day 2020, featuring the top security camera and smart home device discounts

Find the top early smart home automation and home security camera deals for Amazon Prime Day, together with all the best deals on Ring Floodlight Cams & Doorbells, Ring Alarm, Google Nest Cam & Thermostat, Arlo Indoor & Outdoor Cams, Philips Hue lighting kits, and Blink compact cameras. Links to the top deals are listed below.

Save up to 49% on Ring Video Doorbell & Doorbell Pro, chargers & kits – at the Amazon Prime Day sale

Save up to 20% on Ring Security Cameras, Floodlight Cams, Alarms & Security Systems – at the Amazon Prime Day sale

Save $68 on the Ring Peephole Cam with Echo Show 5 at Amazon – easily upgrade your front door with this 1080p video doorbell and see visitors with the included smart display

Save $54 on the Ring Video Doorbell Pro with Echo Show 5 at Amazon – highly rated Certified Refurbished bundle for front door monitoring

Save $50 on the Ring Alarm 14-pc kit with Echo Dot at Amazon – 2nd Gen DIY alarm system that fits 2-4 bedroom homes, with hands-free voice control via Alexa

Save up to $40 on Nest Thermostats, Indoor & Outdoor Security Cameras & Nest Protect – at the Amazon Prime Day sale

Save up to 45% on smart home security cameras at the Amazon Prime Day sale – check the latest deals on indoor & outdoor security cameras from top-rated brands

Save up to 34% on Arlo Pro & Ultra Security Camera Systems – at the Amazon Prime Day sale

Save 25% on the AVANTEK D-3B Waterproof Door Bell Kit at Amazon – comes with 2 wireless transmitters that works within 1,312 ft range and can withstand harsh weather conditions

Save $60 on the HeimVision WiFi Home Security Camera System at Amazon – watch over your home in clear 1080p HD videos that can be viewed on PC, tablet, or smartphone

Save $32 on the Honeywell Home Wi-Fi Smart Color Thermostat at Amazon – Alexa-ready and can set schedules up to 7 days

In need of some more smart home security and automation deals? Check out Amazon’s Prime Day 2020 page to view all the active offers available now.

Amazon Prime Day sales are active for a certain time period. Deal Stripe earns commissions from purchases made using the links provided.

Amazon Prime Day is a celebratory shopping event for Prime members, rewarding them with exclusive access to special deals and huge savings across over a million items.

Not yet a member of Amazon Prime? Start your 30-day free trial now and unlock the entire Prime Day sale.

Prime Day 2020 is a great time to shop for smart home and security cam deals and this year there’s several impressive savings available. Amazon’s line of smart home devices has everything covered. Considered to be the spiritual successor to the Amazon Cloud Cam, Ring fills in the gap for smart doorbells and alarms, including floodlight cams for added security. For instance, the all-new Ring Video Doorbell now has enhanced motion detection and night vision compared to the previous iteration. Blink is also a good pick for a more basic and affordable security system.

The Google Nest family has doorbells and indoor and outdoor security cameras as well, namely the Hello Doorbell and Cam IQ. Nest takes a step further with its Learning Thermostat and Thermostat E, helping save energy and, by the same token, money while keeping rooms nice and comfortable. In addition, Protect is a game-changing smoke alarm that can warn users via phone alerts of any possible fire wherever they are, making it an essential smart home device.

Meanwhile, the Arlo Pro 3 continues to be a popular choice for home security. For one thing, it has 2K HDR support, color night vision, and 160-degree field of view. There’s also the Arlo Ultra that ups the ante with 4K HDR and a 180-degree view.

Beyond the Ring doorbells, Nest thermostats, and whatnot, the Philips Hue range takes smart home lighting to new heights. For starters, its LED bulbs can change the atmosphere of a room in a snap. Moreover, the Play gradient lightstrip changes up the whole home entertainment experience by adapting and working in tandem with any media content on TV.

This year’s later date for the sale makes it the first Prime Day to take place outside of the traditional summer season.

Want some more home surveillance and security equipment deals? Click here to access the full selection of live deals on the Amazon Prime Day sale page.

About Deal Stripe: Deal Stripe shares e-commerce and sales news. As an Amazon Associate Deal Stripe earns from qualifying purchases.

Some U.S. financial markets will be open, and some closed, next Monday, October 12 in observance of the federal holiday Columbus Day.

A former New York wine distributor who hawked a single-serving wine glass that appeared on “Shark Tank” was sentenced to two years in prison Friday for wire fraud.

EV stocks have soared 500%, 800%, even 1,000% this year. But legendary investor Whitney Tilson says the biggest part of this story is coming soon.

(Bloomberg) — It took Soraya Bagheri a day to learn that 450 shares of Moderna Inc. had been liquidated in her Robinhood account and that $10,000 in withdrawals were pending. But after alerting the online brokerage to what she believed was a theft in progress, she received a frustrating email.The firm wrote it would investigate and respond within “a few weeks.” Now her money is gone.Bagheri is among five Robinhood customers who recounted similar experiences to Bloomberg News, saying they’ve been left in limbo in recent weeks after someone sold their investments and withdrew funds. Because the wildly popular app has no emergency phone number, some said they tried in vain to intervene, only to watch helplessly as their money vanished.“A limited number of customers appear to have had their Robinhood account targeted by cyber criminals because of their personal email account (that which is associated with their Robinhood account) being compromised outside of Robinhood,” a spokesman for the company said in an email. “We’re actively working with those impacted to secure their accounts.”The issue didn’t stem from a breach of Robinhood’s systems, the spokesman said.SEC, FinraBagheri, a Washington attorney, and three other Robinhood users said they also contacted authorities including the Securities and Exchange Commission and the Financial Industry Regulatory Authority. Two of those customers said they have heard back from an official at the SEC seeking more information.Finra and the SEC declined to comment.Robinhood, founded seven years ago and based in Menlo Park, California, has exploded in popularity this year as millions of Americans stuck at home — including throngs of millennials — look to make some money during a pandemic that has sent stock prices swinging. But the no-fee brokerage app has also attracted consumer complaints, with novice investors confused by the vagaries of stock options and margin loans.Now, even though the firm said this year that it has more than doubled its customer-service team, clients complain they’re struggling to get quick help when their funds are disappearing.“They don’t have a customer service line, which I’m quite shocked about,”Bagheri said.‘ Mental Stress ’Pruthvi Rao, a Chicago software engineer, said his account was hit on Oct. 6. His bet on Netflix Inc. was liquidated and $2,850 was soon withdrawn. He said he’s sent more than a dozen emails to Robinhood’s customer support address, and that he even tried messaging some of the brokerage’s executives on LinkedIn.“I’m in tremendous mental stress right now because this is all of my savings,” said Rao, 36, whose account was frozen by Robinhood in response to the fraudulent activity. He said Robinhood contacted him on Friday and unlocked the account after sending several emails late Thursday asking for help.Rao showed Bloomberg the same emailed response from Robinhood that Bagheri received. “We understand the sensitivity of your situation and will be escalating the matter to our fraud investigations team,” Robinhood customer service agents wrote them. “Please be aware that this process may take a few weeks, and the team working on your case won’t be able to provide constant updates.”Rao said he had previously set up two-factor authentication to access his account, and Bagheri said she’s certain her Robinhood password is unique from all others, including her email. Neither believed they had been duped by phishing scams or malware. Both said they use the same email for Robinhood and other accounts, and that only Robinhood has been affected.“Unfortunately, it’s a common occurrence that online accounts of monetary value are bought, sold and traded by cyber-criminals,” said Mark Arena, CEO of Intel 471, which monitors activities of digital criminals. “This shows the importance of people practicing common information-security hygiene such as not re-using the same password across multiple accounts and enabling two-factor authentication, which Robinhood supports.”Stock, BitcoinThey also said Robinhood’s online portal showed their money went to a recipient at Revolut, another popular financial-technology startup. London-based Revolut, which offers a money transfer and exchange app, expanded to the U.S. this year.“Revolut has been made aware of the issue and is investigating urgently,” a company spokesman said Friday in an email.Bill Hurley, who owns a metal-fabrication shop in Windsor, Connecticut, said he received notifications that stock and Bitcoin had been sold from his account on Sept. 21, and that $5,000 was transferred to Revolut accounts in two transactions. He said he emailed Robinhood for assistance while the transactions were pending but received none.“They’ve had more than enough time to deal with this,” he said.Hurley, 56, said he reached out to the SEC and heard back from a lawyer for the regulator, who asked for additional information on what had happened.After more than two weeks of emails seeking help from Robinhood, a customer support representative called him on Thursday, he said.(Updates with cyber-security expert comment in 15th paragraph. A previous version of this story corrected Rao’s age.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

Which stocks are always on investors’ wish lists? Growth stocks. Time and time again, the pros on the Street point to tickers with above-average growth prospects as must-haves, as they stand to deliver major rewards in the long run. We really aren’t joking when we say above-average. Stocks that fall into this category have already notched impressive gains year-to-date, but this is only the beginning. The wins could keep on coming through 2020 and beyond. Having a target in mind is one thing, but how exactly are investors supposed to track down these names? This is where TipRanks can come in handy. Using TipRanks’ database, we scanned the Street for analyst-approved stocks that have exhibited a stellar run-up in 2020, and are poised to climb higher in the year ahead. Here are all of the details. Stamps.com (STMP) Providing online mailing and shipping services, Stamps.com makes it easy for its customers to print U.S. Postal Service-approved postage. Even though shares have already jumped 215% year-to-date, some analysts think this name has more room to run. After a recent conversation with management, National Research’s Allen Klee has high hopes for STMP. The analyst tells clients his primary takeaway was “Stamps.com is positioned to benefit from accelerating ecommerce demand.” What’s more, he believes the deep functionality, integration, carrier relationships and processing speed of its products give it a leg up. When it comes to STMP’s revenue, 80% comes from shipping, which makes it “levered to positive ecommerce trends,” in Klee’s opinion. He noted, “We would expect shipping to increase as a percent of total revenue over time. In addition, the company will get international growth and potential market share gains, in our view.” Klee added, “The company has improved their growth outlook and lowered their risk profile through expanding their offerings and services, investing internationally and diversifying carrier relationships.” These investments are related to technology for MetaPack and ShipStation, two companies it acquired, and ShipEngines, its multi-carrier shipping platform. When the spending on these areas of the business moderates, the analyst thinks STMP’s already strong margins will get a boost. Along with the fact that STMP doesn’t have large exposure to any one sector, Klee argues its new partnership with UPS presents an exciting long-term opportunity. “As Stamps.com has eliminated its exclusivity with USPS, they are at various stages of negotiations with various carriers,” he mentioned. The company’s guidance for 2020 does assume a decline in 2H20 compared to the first half of the year, but this is related to how much of the spike in ecommerce demand witnessed in Q2 2020 is sustainable and the impact of the weak macro environment. That being said, Klee highlights new data on customer adds that is “of comparable quality” to past data. Additionally, according to the analyst, “positive data points come from FedEx’s August 2020 quarterly revenues being up 11% from the prior May 2020 quarter and Pitney Bowes on their Q2 2020 earnings call guiding for their global ecommerce segment revenues in Q3 2020 to be comparable to levels from Q2 2020.” The fourth quarter is also historically the strongest quarter for ecommerce given holiday sales. As for competition in the space, Amazon is turning into a major player. With the giant posing a threat to other carriers, Klee thinks STMP can help those that want to improve their offerings. Everything that STMP has going for it convinced Klee to leave his Buy rating as is. Along with the call, he keeps the price target at $390, suggesting 48% upside potential. (To watch Klee’s track record, click here) Looking at the consensus breakdown, 2 Buys and 1 Hold have been issued in the last three months. Therefore, STMP gets a Moderate Buy consensus rating. Based on the $336.67 average price target, shares could surge 28% in the next year. (See Stamps.com stock analysis on TipRanks) Farfetch (FTCH) On to another name that could benefit from accelerating ecommerce trends, Farfetch is an online luxury fashion retail platform that sells products from boutiques and brands from around the world. Up 157% year-to-date, several members of the Street believe this name is still heating up. Writing for J.P. Morgan, five-star analyst Doug Anmuth tells clients that amid broader weakness in the space, “Farfetch stands out as a more valuable and differentiated partner.” Expounding on this, Anmuth commented, “We believe Farfetch became an increasingly important partner to boutiques, brands, and other retail partners during the height of COVID-19 as many physical stores closed and even some online competitors were unable to ship from their distribution centers. For many partners, Farfetch was the only way they could generate sales during the pandemic.” As a result of this, boutiques, brands and department stores added more inventory to the Marketplace (MP), as well as increased reliance on Farfetch Platform Solutions (FPS). This is evidenced by its earnings results for Q2 2020. During the quarter, the acceleration of the secular shift fueled Digital Platform gross merchandise value (GMV) of $651 million, up 34% year-over-year and above the recently revised expectation of $605-$630 million. Additionally, FTCH saw record-high in-season stock levels, with 380,000 stock keeping units across 3,500 brands, from 1,300 sellers including 500 direct brand e-concessions. There was a 60% increase in traffic and a doubling of app installs in Q2, leading to the addition of 500,000 new customers. Anmuth also noted, “With direct brand e-concessions (EC) at 50%-plus of all inventory in the MP, the top 20 direct EC brands doubled their sales year-over-year.” Looking ahead, management expects Digital Platform GMV to ramp up to 40-45% growth in Q3, thanks to the early recovery in China, Western Europe and the Middle East, as well as a late Q2 pick-up in the U.S. On top of this, a number of key initiatives could propel the company forward, in Anmuth’s opinion. New Guards Group (NGG), which has been controversial among investors, drove $66 million in brand platform revenue and GMV, even though there were some delays in Fall-Winter shipments as retailers worked through Spring-Summer inventory. Off-White is cited as another point of strength, with the launch of Harrods also benefiting FTCH. To sum it all up, Anmuth said, “Overall, we recognize that FTCH benefited from a favorable environment with multi-year acceleration of luxury ecommerce adoption. But we expect trends to remain elevated as consumers increasingly value the ease and convenience of FTCH’s platform, and brands and boutiques add greater inventory. We think FTCH is better positioned than any time since its IPO having made significant strides in direct brand e-concessions and adding selection from NGG, while also showing greater cost discipline and commitment to EBITDA profit in 2021.” Based on all of the above, Anmuth stayed with the bulls, reiterating an Overweight rating and $40 price target. Investors could be pocketing a gain of 50%, should this target be met in the twelve months ahead. (To watch Anmuth’s track record, click here) Turning to the rest of the Street, the bulls have it on this one. With 8 Buys, 1 Hold and 1 Sell, the word on the Street is that FTCH is a Moderate Buy. At $31.70, the average price target implies 19% upside potential. (See Farfetch stock analysis on TipRanks) Chegg (CHGG) As an education technology company, Chegg provides digital and physical textbook rentals, online tutoring and other student services. This name has skyrocketed 114% in 2020, but there’s still plenty of fuel left in the tank, so says Wall Street. Among the fans is Craig-Hallum’s Alex Fuhrman, who remains confident after CHGG’s Q2 earnings release. He told clients, “Chegg has been firing on all cylinders in 2020, and yesterday’s big beat suggests that the company is rapidly scaling its international business as the shift to online and hybrid learning has accelerated adoption abroad as well as domestically.” In Q2, new subscriber growth ramped up dramatically as colleges around the country and the world made the switch to virtual learning. Excluding the acquisition of Mathway, Chegg’s membership base grew 58% year-over-year at the end of Q2, significantly ahead of management’s guidance of 45%. What was behind this strong showing? According to Fuhrman, increased international subscriptions contributed to the solid performance, and management believes that the long-term opportunity outside of the U.S. is even bigger than the domestic one. Going forward, Fuhrman points to the launch of the Chegg Study Pack bundle as a major possible catalyst. On top of this, an accelerated focus on reducing password sharing could have a “meaningful positive impact on results in 2H20 and especially in 2021.” Based on these catalysts, he argues that his estimates might be conservative and have the potential to move higher throughout 2020. It should also be noted that the peak fall rush season might not be fully accounted for in management’s guidance, in Fuhrman’s opinion. Therefore, the analyst sees “opportunities for Chegg to beat estimates in the back half of 2020 whether students are on campus or not.” He added, “Even if college enrollments drop significantly for the upcoming fall semester (a real possibility), we believe Chegg’s addressable market won’t materially change given the significant number of students who will likely still take at least a few classes at a local college or community college, whether online or in person.” All of this prompted Fuhrman to conclude, “The pandemic is rapidly accelerating Chegg’s growth, and increased international adoption could support elevated growth rates for years even in a post-pandemic world.” Taking the above into consideration, Fuhrman maintains a Buy rating and $105 price target. This target conveys his confidence in CHGG’s ability to climb 29% higher in the next year. (To watch Fuhrman’s track record, click here) Most other analysts echo Fuhrman’s sentiment. 10 Buys and 2 Holds add up to a Strong Buy consensus rating. Given the average price target of $95.25, the upside potential comes in at 17%. (See Chegg stock analysis on TipRanks) Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

The clock just started on the biggest financial event in 20 years. Fortunes will be made and lost. Here’s how to prepare – before 2020 comes to an end

On Thursday, Carnival Corp (NYSE:CCL) gave a sobering business update. While bookings for 2021 have somewhat recovered, the update also revealed that Carnival had used every financial maneuver to raise liquidity. Carnival stock sank 3%, adding to its year to date (YTD) -67% loss.
Source: Ruth Peterkin / Shutterstock.com

Today, investors have priced Carnival stock as if the world’s largest cruise line will never recover. Its two smaller rivals, Norwegian (NYSE:NCLH) and Royal Caribbean (NYSE:RCL), on the other hand, are valued as if nothing’s wrong in the world. It’s a massive disconnect from reality.
And that opens an opportunity. Carnival remains stronger than its two rivals, so investors looking to profit from a recovering economy should consider a paired long-short strategy. In other words, buy CCL and cover with an NCLH/RCL short. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Carnival Stock Is a 200% Return Opportunity
As a tech-focused growth investor, I tend to pass on capital-intensive companies like cruise lines. Despite decent profits, these companies are endless cash pits; the billions of dollars needed to build their ships drag down return on capital invested (ROIC). And that reduces long-term investor returns. Over the past decade, no publicly listed cruise line has outperformed the S&P 500.
These, however, are extraordinary times. With Carnival Cruise lines trading at just 0.6 times book value (compared to its long-term average of 1.9 times), even growth investors would be foolish to ignore this opportunity.

7 Innovative Stocks That Will Disrupt Their Sectors

The Cruise Industry: Beaten Down and Cheap
After years of consolidation, Carnival and its two rivals, Royal Caribbean and Norwegian, now make up almost three-quarters of the world’s cruise industry. That means before the coronavirus pandemic, industry profits were relatively high and stable; since 2000, only Norwegian had lost money in any given year.
Source: Data courtesy of Cruise Market Watch
But that was before Covid-19.
Since March, revenues at all three cruise lines have tumbled to almost zero. Though some cruise lines are slowly resuming limited European routes, U.S. “no-sail” orders still prohibit all cruises from the world’s largest market until at least Oct. 31. Analysts expect the recovery could take years.
Carnival, however, stands to weather the storm.
The Best Capitalized of the Big-3
Of the three major cruise lines, Carnival holds the least debt. Even now, its 1.1 times debt-to-equity (D / E) ratio is far lower than RCL’s 2.2 and Norwegian’s 2.4. (It’s also true when you include second lien debt)
Carnival is also the most consistently profitable. It earned the highest return on assets (ROA) in 2019.
CCL: 6.8%
RCL: 6.5%
NCLH: 5.8%
Though it’s low leverage depressed ROE (a profitability measure that includes debt) in good times, the company’s financial prudence pays off in bad.

CCL Stock: The Poster Child of the Coronavirus
Yet, Carnival is the cheapest of the three cruise lines. Why?
Early in the coronavirus pandemic, Carnival had the great misfortune of picking up not just one, but two high-profile outbreaks of the time.
Diamond Princess. The first super-spreader event outside China. By late February, the Carnival-owned vessel, docked in Yokohama Bay, accounted for over half of known non-China infections.
Grand Princess. Among the first wave of coronavirus cases to reach the U.S. After docking in Oakland, the ship accounted for the first known person in California to die of the virus at the time.
Princess Cruises also happens to be Carnival’s largest brand, making up almost a quarter of the cruise line’s revenues.
Today, Carnival trades for the cheapest on tangible book…
CCL: 0.6x
RCL: 1.9x
NCLH: 1.2x
…and on the price to cyclically adjusted PE (CAPE) ratios
CCL: 7.5x
RCL: 20.6x
NCLH: 16.5x
More advanced DCF modeling and ratios also show the same story.
But investors shouldn’t lose sight of the long term. The cruise industry has recovered from multiple rounds of both the Norovirus and Legionnaires’ disease before. And with a vaccine on the horizon, the industry should recover from the coronavirus pandemic as well.
Going Long/Short with Carnival
What should investors do with Carnival Stock? First, let’s calculate its value. Using consensus estimates of a 2023 return to normalcy and factoring the company’s B1 bond rating (implying a 24.8% chance of bankruptcy), a two-stage DCF model shows a fair value of $46, almost a 200% upside. That would mean a 16.5 times CAPE ratio.
But before investors open their checkbooks, know this: there are still some long-term risks to the cruise industry. Firstly, rival Norwegian could go bankrupt. That would roil the market for second-hand cruise ships, making it harder for Carnival to mortgage or sell their vessels. Secondly, Carnival could still run out of money if “no-sail” orders get extended another 24 months. Even its financial resources aren’t infinite. Finally, a sudden increase in interest rates could make the company’s debts unserviceable.
To close out these three risks, investors should turn to a long-short strategy. Using the same valuation methods for Carnival’s competitors show:
NCLH: Fair value = $20.5 | 14% upside
RCL: Fair value = $63.5 | -7% downside
Norwegian, with a far higher debt load, is the far most vulnerable to bankruptcy. Royal Caribbean is overpriced. Either should make a good pair with CCL for a long/short trade.
It’s going to be a slow recovery for Carnival: generating $2 billion of free cash flow still means taking 4-5 years to fix its balance sheet. But for those foreseeing a quick coronavirus recovery, it’s essential to pull the trigger now.
On the date of publication, Tom Yeung did not have (either directly or indirectly) any positions in the securities mentioned in this article.
Tom Yeung, CFA, is a registered investment advisor on a mission to bring simplicity to the world of investing.
More From InvestorPlace

Why Everyone Is Investing in 5G All WRONG

America’s #1 Stock Picker Reveals His Next 1,000% Winner

Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company

Could Tiny “Super” Battery Kill Big Tech?

The post There’s a 200% Upside for Long/Short Investors in CCL Stock appeared first on InvestorPlace.

Internet of Things stocks continue to see strong growth when it comes to market size. But from my observation, neither investors nor consumers have grasped just how large this market will become.
Year by year, more and more devices are linking up. That’s creating a rich web of connected devices, meaning an explosion in data, and therefore a need for faster internet infrastructure.
As a result, there’s an entire realm of growing stocks that are benefiting from the Internet of Things (IoT). It’s also a group that will continue to benefit from growth for years to come, particularly as connectivity infrastructure builds out and 5G networks become mainstream.InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Once upon a time, you would walk into a coffee shop and pray it had even a shoddy WiFi connection. Now it’s a shock to walk into a coffee shop, library or many other types of establishment and not have a pretty good connection.
It goes beyond that as well. The number of smart homes in the U.S. is forecast to climb from roughly 20 million in 2019 to more than 46 million in 2025. In 2018, there were 22 billion devices connected to the internet. That figure is forecast to climb to 38.6 billion in 2025 and hit 50 billion by 2030.

7 Innovative Stocks Pushing Our World Ahead

Here are 7 Internet of Things stocks to watch going forward:
Year (NASDAQ:YEAR)
Qualcomm (NASDAQ:QCOM)
Intel (NASDAQ:INTC)
Alteryx (NASDAQ:AYX)
Fastly (NYSE:FSLY)
Apple (NASDAQ:AAPL)
Honeywell (NYSE:SHE)
Data volume from IoT connections is forecast to climb from 13.6 zettabytes in 2019 — a zettabyte is equal to 1 trillion gigabytes — to 79.4 zettabytes in 2025. That’s a huge growth runway from here.

Year (YEAR)
Source: JHVEPhoto / Shutterstock.com

Some investors may find Roku as an unexpected pick to lead our list of Internet of Things stocks. After all, it’s more a streaming video platform than a pure-play IoT name. That said, its internet-connected devices stand to profit from this trend just the same.
A recent breakdown of connected devices shows just how important video is to the industry. In 2020, smart TVs had the third-highest average number of connected devices in U.S. households, trailing just mobile devices and computers. The connected TV box was fifth-highest.
In the second quarter of 2019, Roku reported 8.8 billion streaming hours. In Q2 2020, that figure accelerated significantly, up to 14.6 billion hours, a ~66% increase.
While Roku does not generate much profit on the sale of its hardware, it does make a large amount of money through advertising revenue. The more Roku-powered smart TVs and Roku devices that are out there, the more streaming that takes place and the more ad revenue the company generates.
I like this play on streaming video, as it’s clear the cable-cutting trend is the one favored by consumers. While many find Roku stock as a high-growth name, keep in mind it is only recently hitting new all-time highs.
As a result, the stock isn’t as stretched as some of its growth peers and Roku’s next leg higher could provide strong returns to investors.

Qualcomm (QCOM)
Source: jejim / Shutterstock.com

A more traditional play on the Internet of Things is Qualcomm. This company has its fingers in everything, but it’s a major player in the smartphone game.
When investors are talking about connected devices, it’s easy to think of drones and smart fridges. But let’s not overlook the most glaringly obvious component of all, which is smartphones. Whether it’s Android or iOS, it doesn’t matter. Qualcomm plays a role and as a result, it’s a very steady play on the IoT market.
It was in a nasty legal fight with Apple at one point. But last year — unexpectedly — the two resolved their issues overnight. Apple dropped its case, paid Qualcomm, and came to a multi-year agreement with the chipmaker.
While Apple will likely migrate to its own chips in the future, Qualcomm should still have a good run with the iPhone-maker.
It helps that Qualcomm pays out a respectable 2.2% dividend yield and has a reasonable forward valuation. While shares trade at 29 times this year’s estimates, Qualcomm trades at just 18.5 times 2021 expectations.

7 Innovative Stocks Pushing Our World Ahead

Although estimates call for modest earnings and revenue growth this year, expectations call for 64% earnings on 32% revenue growth in 2021.

Intel (INTC)
Source: Sundry Photography / Shutterstock.com

Like Qualcomm, Intel is another major chipmaker in the IoT space. It has shown its prowess in the past, such as when it does coordinated and synchronized drone shows with its products.
The company’s products are in everything from the data center, to Mac computers, drones and self-driving cars. However, many investors fail to realize that they’re also in a plethora of healthcare, banking, education and government applications as well.
Put simply, Intel has its hands in everything on the Internet of Things front. While it doesn’t boast the most robust growth overall, its IoT unit is rather formidable.
I like Intel for another area, too: edge computing and data center revenue.
As more IoT devices connect to the internet, the more data that is created. That is, more texts, more pictures and more information. As data grows, data centers grow. As IoT device usage grows, the more companies that will rely on edge computing.
Intel selling into those industries will help drive future growth for the company, particularly at a time when it really needs that growth.

Alteryx (AYX)
Source: Shutterstock

Speaking of the creation of data, let’s not forget about Alteryx. The fast-growing software company is one to keep an eye as we progress into the future.
Admittedly, the stock is a bit on the expensive side. However, shares were hammered in August when the company reported disappointing guidance. Simply put, management issued conservative guidance given the uncertainty surrounding Covid-19. With the explosion in new IoT growth, those clients won’t stay on pause for long.
Case in point? Two months later the company came out and reissued third-quarter guidance. This time, the figure came in well ahead of the consensus estimates analysts were expecting when Alteryx reported earnings. That spending is back and it’s likely to accelerate.
I think the panic selling from last quarter makes this a great buying opportunity. It’s one of the few high-quality profitable, cash-flow positive growth companies out there that’s not at or near its highs.

7 Innovative Stocks Pushing Our World Ahead

Better yet, it has long-term secular growth in front of it. Using A.I., the company can help connect the dots where there is seemingly no correlation. It can improve efficiency and make sense of the unintelligible.

Fastly (FSLY)
Source: Pavel Kapysh / Shutterstock.com

I could name every chipmaker under the sun when it comes to the Internet of Things stocks. However, I don’t want to do that. I want to focus on the best plays in the IoT space.
That means covering multiple industries and different crevices of the group. Just as Alteryx will benefit from a massive influx of data in the ensuing years, Fastly will benefit from an increase in edge computing.
Fastly became a Wall Street darling this year, exploding from around $12 near its March lows to almost $120 near its summer highs. While the stock has swooned a bit since that run, it still has long-term opportunities. That’s particularly true if investors can nab this name on a deep discount.
The company is getting into the black this year amid strong revenue growth. What people don’t realize is the longevity in the growth, though.
This is not a couple quarters of accelerated growth or a strong year before fading back to reality. Edge computing is going to see more and more demand as the world continues its digital transformation. Covid-19 isn’t creating a temporary boost; it’s creating a permanent shift in the way we live.
As the edge sees more demand — ranging on everything from Uber (NYSE:UBER) to Amazon (NASDAQ:AMZN) — Fastly is going to be a beneficiary.

Apple (AAPL)
Source: denizn / Shutterstock.com

Getting to one of the more traditional Internet of Things stocks, Apple simply has to be on the list.
The company is one of the largest in the world. It has a cash hoard larger than many countries and is one of most well-known brands on Earth. One could say that the Apple Watch is what gives it the IoT touch. I would say it’s everything.
Every one of its devices connects to a tower, WiFi or both. That goes for iPhones, iPads, Macs and the Apple Home, TV and Watch. Earlier this year, Apple had more than 1.5 billion active devices in the world.
That’s a massive footprint on the IoT space — and it makes sense. I imagine a number of our readers are seeing this article on a Mac, and many users have two or three other Apple devices connected to the internet at a given time.
Don’t expect the company to slow down anytime soon, either. It’s introducing a slew of new products. While the coronavirus disrupted consumers and supply chains, Apple is forecast to get back on track in 2021. Estimates call for double-digit revenue growth and almost 20% earnings growth.

7 Innovative Stocks Pushing Our World Ahead

Also keep in mind, we don’t have to wait long for fiscal 2021, which just began after September. Apple stock has run hard and has now pulled back. Perhaps it will dip further, but bet against Apple at your own peril. This name is a long-term juggernaut.

Honeywell (SHE)
Source: josefkubes / Shutterstock.com

We’ve covered the chipmakers, streaming-video plays, data and edge-computing companies and now the real consumer IoT products. That includes names like Apple, Honeywell and many others.
However, Honeywell is one that investors tend to overlook when it comes to tech. That’s because it’s technically classified as an industrial stock — and it doesn’t get the credit it deserves.
While some may recognize Honeywell from their smart thermostat or home security, it’s actually a much bigger IoT play than that. The company has now launched the Industrial Internet of Things:
“a network of networks that uses the internet to connect people, processes and assets enabling a new way to optimize business results… [That leverages] smart connected assets, enterprise integrated automation, secured cloud-based data and advanced analytics.”
With the industrial IoT, Honeywell sees a juicy pie sitting in front of it and it’s not letting some other company eat it.
The stock kicks out a 2.2% dividend yield to sit through a slight decline in sales and revenue this year. However, it’s forecast to pump out double digit top- and bottom-line growth next year, while the stock is still ~7% below the 2020 highs. That still gives investors a chance to get in, particularly on a dip.
On the date of publication, Bret Kenwell held long positions in ROKU, AYX, AAPL and FSLY.
Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell.
More From InvestorPlace

Why Everyone Is Investing in 5G All WRONG

America’s #1 Stock Picker Reveals His Next 1,000% Winner

Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company

Could Tiny “Super” Battery Kill Big Tech?

The post 7 Internet Of Things Stocks To Buy For 2021 And Beyond appeared first on InvestorPlace.

I had never heard of Snowflake (NYSE:SNOW) until I read that Warren Buffett bought $250 million of SNOW stock at the IPO price of $120 and another 4.04 million shares from an existing shareholder.
Source: Sundry Photography / Shutterstock.com

Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B) bought a total of 6.12 million shares for approximately $730 million. As I write this on Oct. 8, Berkshire is sitting on an unrealized profit (maybe it’s already sold them) of $743 million.
Not a bad month’s work for the boys at America’s largest conglomerate. InvestorPlace – Stock Market News, Stock Advice & Trading Tips
SNOW Stock Delivers Healthy Gains
Given Buffett’s distaste for buying IPO stocks — Buffett last bought shares of Ford (NYSE:F) in 1956 — most believe that either Todd Combs or Ted Weschler was responsible for the trade.

7 Innovative Stocks Pushing Our World Ahead

“The idea of saying the best place in the world I could put my money is something where all the selling incentives are there, commissions are higher, the animal spirits are rising, that that’s going to better than 1,000 other things I could buy where there is no similar enthusiasm. … doesn’t make any sense,” Buffett stated in a 2019 CNBC interview.
Buffett’s not the only billionaire portfolio manager that’s not a fan of IPOs. I often like to quote Canadian money manager Stephen Jarislowsky, who wrote in his 2005 book, The Investment Zoo, that more often than not, investors can buy shares within 12-24 months for less than the IPO price.
Will you be able to buy SNOW for less than $120 at some point between now and September 2022?
I can’t tell you if the latest tech darling will experience a major fall from grace over the next two years, but I do think you ought to be able to pick up SNOW stock for less than $200 soon. That’s because an annualized return of almost 1,300% is tough to hold on to, no matter how good a company we’re talking about.
Forget Snowflake’s Name and Focus on Its Strengths
Before discussing why I think the long-term prospects for Snowflake and its business are good, let’s get the elephant in the room out of the way so we can move on to important subjects.
A September article from Street.com lays out the reasons for its silly name.
While co-founder Marcin Zukowski gives three reasons for naming the company Snowflake, Zukowski’s admission that most of the founders were fans of the mountains, snow, and skiing brought them to name it something totally nonsensical.
Don’t get me wrong; I’m not saying this because I have a giant pole up my keister; I believe good company names often help identify what a business does to make money. Snowflake does none of that.
Fortunately for SNOW shareholders, what’s most important to its business’s success is a focus on executing its growth strategy and being willing to pivot when your customers tell you to.
It isn’t easy to do.
Its Strengths Are What Matter
InvestorPlace contributor Divya Premkumar recently discussed why Snowflake stock is worth the hype.
She focuses on two ideas: The first being that Snowflake has over 3,100 clients helping each of them take their databases for the cloud to the next level. Product means something, but as I said, so does execution, and that’s where chief executive officer Frank Slootman comes into play. Slootman is a veteran of the tech industry and knows what he’s doing.
“The tech veteran managed a slew of high-growth tech companies before Snowflake. His goal was to create a product that would help companies store and manage their digital data,” Premkumar stated on Oct. 7.
“A function that became increasingly important during the pandemic. Slootman also adopted a subscription-based model that helped Snowflake stand out from a sea of competitors.”
Growth is the Prediction
Quality product, significant target market, and excellent management translate to manageable, ultimately profitable growth.
Through the first six months of 2020, Snowflake had operating losses of $174.1 million from $242.0 million in sales. That might seem horrendous until you consider that its operating margin went from -176% in the first six months of 2019 to -72% in the latest six-month period.
A few more quarters of growth while managing its expenses and Snowflake could be making money on a GAAP basis, never mind a non-GAAP profit.
In Snowflake, Buffett’s investment lieutenants saw a cloud-based business that is markedly different from many of its peers. That doesn’t mean they won’t take profits. But even if they do, dumb name or not, I don’t think you should take a pass on Snowflake stock.
Bottom Line on SNOW Stock
My suggestion is you buy a quarter position now and wait to see if it falls below $200. I’d fill a half position if it does, leaving a little dry powder should it fall back to its IPO price.
That said, expecting it to fall by 50% to $120 might be asking for too much. Long term (2-3 years), I could see Snowflake trading much higher.
On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article.
Will Ashworth has written about investments full-time since 2008. Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities.
More From InvestorPlace

Why Everyone Is Investing in 5G All WRONG

America’s #1 Stock Picker Reveals His Next 1,000% Winner

Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company

Could Tiny “Super” Battery Kill Big Tech?

The post Snowflake Might Be a Terrible Name But Donâ????t Let That Stop You From Investing appeared first on InvestorPlace.

Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?

Fortunately, this “knowledge” never greatly influenced my investment strategy. Meanwhile, Wall Street wants to convince you that you know something about the future, so you actively manage your portfolio and thereby fatten the Street’s coffers. In the financial markets, action almost always triggers investment costs and perhaps big tax bills.

Third-quarter earnings season kicks off this week in earnest with a plethora of major banks reporting results.

Our technology will match you with the best lenders at super low rates. Trusted by over 15 million. Save thousands each year. 2.39% APR

The stock market rally is the best of both worlds, so investors should hit the ground running. The Apple iPhone event, Amazon Prime Day are among leaders with key news this coming week.

Out on Wall Street, elections are the talk of the town. As President Trump’s battle against COVID-19 wages on, Biden has taken the lead in the race to the White House, with a Reuters poll conducted on October 2-3 putting the former Vice President ahead by 10 percentage points. Against this backdrop, fears of a blue wave (a Democrat-controlled presidency, Senate and House) are washing onto the Street. However, Goldman Sachs believes a blue wave might not be such a bad thing for the U.S. economy. “All else equal, such a blue wave would likely prompt us to upgrade our forecasts. The reason is that it would sharply raise the probability of a fiscal stimulus package of at least $2 trillion shortly after the presidential inauguration on January 20, followed by longer-term spending increases on infrastructure, climate, health care and education that would at least match the likely longer-term tax increases on corporations and upper-income earners,” Goldman Sachs economist Jan Hatzius noted. Bearing this in mind, our focus shifted to two stocks flagged by Goldman Sachs as strong value plays. Running both tickers through TipRanks’ database, we found out what makes each so compelling. General Electric (GIVE) First up we have General Electric, which has been a pioneer in the transportation, power, environmental and healthcare industries for the last 150 years. According to Goldman Sachs, the future looks bright for this name. Firm analyst Joe Ritchie tells clients that in the two years since Larry Culp took over as CEO, the company has placed a significant focus on becoming a “leaner, structurally more productive company with better capital discipline.” “While the pandemic has caused delays in the transformation, we believe GE will emerge as a stronger company. Admittedly, we might be a little early on the turn in the stock, but we believe we are at a bottom from both a fundamental and sentiment perspective, and that is typically the best time to own industrial cyclicals. Our base case assumption is that a vaccine will be mass distributed over the next 12 months and, under this scenario, we believe the second derivative improvement on the resumption of air travel will be significant and many of the underlying concerns on GE’s balance sheet will fall to the background,” Ritchie explained. To this end, the analyst thinks HSD industrial free cash flow margins could be achieved by 2023. However, these expectations could be conservative should commercial aerospace rebound more quickly than Ritchie anticipates. “In the near-term, we believe Industrial FCF bottomed in 1H20 and think GE could generate $1 billion-plus in 2H20 given close to $2 billion in 2H cash actions, high margin outages that were pushed from 1H to 2H, a lower drag from onshore wind installations given the PTC was extended to 2021 and a good recovery in PDx. As a result, we think 2H Industrial FCF could likely surprise to the upside, a potential positive near-term catalyst for the shares,” Ritchie commented. It should be noted that aviation has been GE’s crown jewel segment, but this sector has been hampered by the pandemic as well as two fatal Boeing 737-Max crashes. That said, Goldman Sachs’ global Aerospace team expects commercial AM trends to return to 2019 levels by 2023. Ritchie added, “We estimate there could be an additional $1.3 billion to our Aviation 2023 EBIT forecast if commercial aftermarket were to rebound to 2019 levels by 2023.” On top of this, the Renewables and Power segments could drive upside for GE. “While the COVID-19 pandemic hurt Gas Power demand, we believe the self-help story is firmly in place but still discount management’s expectations for HSD margins in Gas Power in 2021 and we don’t expect Renewables to turn EBIT positive until 2022,” Ritchie mentioned. In line with his optimistic approach, Ritchie stayed with the bulls, reinstating a Buy rating with a $10 price target. Investors could be pocketing a gain of 46%, should this target be met in the twelve months ahead. (To watch Ritchie’s track record, click here) Turning to the rest of the Street, opinions are split evenly. With 6 Buys and 6 Holds assigned in the last three months, the word on the Street is that GE is a Moderate Buy. At $8.20, the average price target implies 20% upside potential. (See General Electric stock analysis on TipRanks) Translate Bio (TBIO) Developing a new class of potentially transformative medicines using messenger RNA (mRNA), Translate Bio hopes to bring new treatments to market for diseases caused by protein or gene dysfunction. Based on its promising technology, it’s no wonder Goldman Sachs is pounding the table. Writing for the firm, analyst Terence Flynn points to its lead candidate, MRT5005, a codon-optimized human CFTR mRNA, which is formulated in lipid nanoparticles that are delivered via a nebulizer, as a key component of his bullish thesis. The therapy is currently progressing through a Phase 1/2 cystic fibrosis (CF) trial. Looking at early clinical data, the asset generated an initial signal of clinical activity. That being said, while an improvement in lung function was witnessed, the results aren’t definitive. Despite the early nature of the data, Flynn sees the next data readout, which is slated for 2021, as a major possible catalyst. “For MRT5005 we see the most straightforward path to market and unmet need being the ~10% of CF patients with splice mutations where Vertex Pharmaceuticals (VRTX)’s drugs are not effective, which we project could be a ~$1.9 billion peak opportunity,” he commented. VRTX has developed several oral drugs called CF correctors or potentiators, that when used in combination improve the function of the existing CFTR protein in the majority of CF patients and thus, drive improved outcomes, which has made them the standard of care. However, these therapies only work in patients with at least one F508del mutation, which represents roughly 90% of patients with CF. For the other 10% of CF patients whose bodies don’t make the CFTR protein, the drugs don’t have anything to target. The analyst added, “TBIO believes there is also significant unmet need beyond this ~10% of CF patients, including an incremental ~20% of patients that either have a suboptimal lung function (FEV1) response to VRTX’s drugs or cannot tolerate them.” If that wasn’t enough, TBIO is collaborating with Sanofi-Aventis on a COVID-19 vaccine, which could make its way to the clinic later this year. To this end, data could come by 1H21. “However, PFE/BNTX’s upcoming Phase 2/3 COVID-19 mRNA vaccine data will likely represent one of the first definitive readouts on vaccine efficacy and safety (in addition to MRNA and AZN) and in our view, there are three likely outcomes, which also have implications for TBIO,” Flynn stated. As part of this collaboration, the companies are also advancing preclinical development vaccine programs against several other targets including influenza, viral pathogens and bacterial pathogens. What’s more, Flynn argues that TBIO represents a possible M&A target as “the company has a novel platform technology (mRNA), a wholly owned clinical stage asset (MRT5005), and a broad partnership covering mRNA vaccines for infectious diseases, which could become de-risked over the near to medium-term.” Given all of the above, Flynn sides with the bulls. To kick off his coverage, he puts a Buy rating and $19 price target on the stock. This target brings the upside potential to 29%. (To watch Flynn’s track record, click here) Are other analysts in agreement? They are. Only Buy ratings, 5 to be exact, have been issued in the last three months. Therefore, the message is clear: TBIO is a Strong Buy. The $27.50 average price target suggests shares could climb 87% higher in the next year. (See Translate Bio stock analysis on TipRanks) Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

On CNBC’s “Fast Money Halftime Report,” traders discussed Goldman Sachsbullish call on General Electric Co. (NYSE: GIVE). Goldman’s analyst reinstated the stock with a Buy rating and a price target of $10, because the company is making progress to be a leaner and structurally more productive company with better capital discipline.Jenny Harrington is not a buyer because the stock is too complex to analyze. She thinks JPMorgan’s Steven Tusa is the best analyst for the stock and he sees no quick turn for the stock.See Also: Goldman Sachs Calls General Electric The ‘Ultimate Self-Help, Vaccine Leverage Story’Michael Farr wants to buy General Electric, but he hasn’t bought it yet. He likes it because of its CEO, Lawrence Culp, who knows how to manage a big conglomerate. Farr is dying to buy the stock, but he just can’t make himself to do it.Jim Lebenthal thinks Caterpillar Inc. (NYSE: CAT) is the best stock in the industrial space. He would rather buy Boeing Co (NYSE: BA) instead of General Electric.Stephen Weiss prefers the chip names. He sees General Electric as the stock where you go when you can’t find anything else. He wouldn’t touch it.Courtesy imageSee more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Cramer Shares His Thoughts On Boeing, General Electric And More * Cramer Weighs In On General Electric, Chevron And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Get a Fidelity portfolio manager’s take on how to seek out opportunities and invest for potential income now, despite low interest rates.

Exxon Mobil is getting booted from the Dow Jones Industrial Average while oil prices remain low. Is the stock a good buy?

After stimulus talks seemed to be off the table just a few days ago, they have been the fuel behind the latest rally. That said, let’s look at a few top stock trades for next week.
Top Stock Trades for Monday No. 1: Microsoft (MSFT)
Click to EnlargeSource: Chart courtesy of StockCharts.com
This name rallied hard into the September highs, along with the rest of the market. And just like the rest of tech, Microsoft (NASDAQ:MSFT) wasn’t immune to the ensuing pullback, either.
The stock sliced right through its 50-day moving average, but was able to find its footing around the $200 mark. Since then, it’s been slowly but surely coming back. On Friday, we had a nice 2% pop in the name.InvestorPlace – Stock Market News, Stock Advice & Trading Tips
However, that pop has sent shares right into the troubling $215 area. The stock has struggled with $215 for a while now, only bursting above it during that late-summer rally. If shares can again clear this mark, it opens up Microsoft to a possible retest of the $230 level.
If $215 is resistance, I don’t want to see shares back below $207. That means it will have lost the 20-day and 50-day moving averages, as well as uptrend support (blue line).

7 Innovative Stocks That Will Disrupt Their Sectors

If that happens, it could put a retest of the September lows back in play at $196.25.

Top Stock Trades for Monday No. 2: AT&T (T)
Click to EnlargeSource: Chart courtesy of StockCharts.com
AT&T (NYSE:T) floundered for a long time, then found its footing and rallied into the upper-$30s. However, shares haven’t made up much ground from the coronavirus selloff.
Shares are doing a solid job of reversing off last month’s low. However, AT&T needs to clear downtrend resistance and the 50-day moving average for bulls to start taking this one seriously.
A break of $28 puts a retest of the September lows back in play. If that fails to buoy AT&T, the $26s could be in play.
Over $29 technically puts the 200-day moving average in play, as well as a gap-fill up toward $31.

Top Stock Trades for Monday No. 3: Workhorse (WKHS)
Click to EnlargeSource: Chart courtesy of StockCharts.com
Workhorse (NASDAQ:WKHS) is quietly trying to get going.
After a breakout in September sent shares to new highs, WKHS pulled back and found support at prior resistance near $20. On Friday shares are up almost 10% and are pushing through downtrend resistance.
It would have the all-clear with today’s move if the 20-day weren’t acting as resistance. On Monday, traders will be looking for a weekly-up rotation over Friday’s high at $26.84 and the 20-day moving average.

9 New-on-Robinhood Stocks You Can Buy Now

If they get it, it could put the $30 to $32 area in play.

Top Stock Trades for Monday No. 4: Domino’s Pizza (DPZ)
Click to EnlargeSource: Chart courtesy of StockCharts.com
Domino’s Pizza (NYSE:DPZ) fell hard on Thursday, dropping almost 7% on disappointing earnings. On Friday, it added to the pain, down another couple of percent.
Thursday’s dip looked indecisive, with DPZ basically holding the 50-day moving average, but finding resistance at the 20-day and support at the 100-day. One had to give way and as of now, it’s the 100-day moving average failing as support.
If the stock reclaims the 100-day moving average, bulls could use the post-earnings low as their stop and look for a squeeze higher.
On the downside, I wouldn’t mind taking a shot at this name in the $375 to $380 area. I prefer this vs. buying a reclaim of the 100-day moving average, as the risk/reward is more attractive. A break of $375 likely puts the 200-day moving average on the table.
Ultimately we want to see shares north of $400 and the 50-day moving average, eventually putting a gap-fill in play up toward $430.
On the date of publication, Bret Kenwell held a long position in T.
Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell.
More From InvestorPlace

Why Everyone Is Investing in 5G All WRONG

America’s #1 Stock Picker Reveals His Next 1,000% Winner

Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company

Could Tiny “Super” Battery Kill Big Tech?

The post 4 Top Stock Trades for Monday: MSFT, WKHS, T, DPZ appeared first on InvestorPlace.

Among millennials this percentage is just 16%. More than 71% of older adults rate themselves as having “high financial knowledge.” The comparable percentage among millennials is only slightly lower at 62%.

All new method to fight neuropathy focuses on the truth of what causes pain and symptoms.

For investors, there’s playing the lottery. And then there’s Sorrento Therapeutics (NASDAQ:SRNE). The unassuming biotech firm initially made headlines in May when it suggested it had a “cure” for coronavirus. SRNE stock initially spiked 140% before investors saw through the misstatement.
Source: Shutterstock

The company then saw its second wave of interest in August after announcing plans for a rapid coronavirus test. As the product failed to materialize, Sorrento fell almost 50%.
But the pain isn’t over yet for Sorrento stock holders. That’s because Sorrento’s ill-fated foray into Covid-19 “cures” is emblematic of the company’s problems.InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Rather than concentrate on creating marketable cancer treatments, management has instead focused on pumping up its share price to buy up questionable moonshots. Why? Its CEO has one of the most absurd compensation structures I’ve ever seen (page 36). Its “tranche” system gives leadership the incentive to shoot for the stars with little regard for investor losses.

7 Innovative Stocks That Will Disrupt Their Sectors

So, while any of these moonshots may prove commercially viable one day, the company is gambling with other people’s money. Investors looking for a flutter might as well play the Powerball. You’ll have a far better shot at becoming a millionaire.
SRNE Stock: The Covid-19 Fiasco
Sorrento has a long history of puffery. Perhaps the best example comes from its attempts to profit from the coronavirus pandemic — in May, the company’s CEO made waves when he announced a “cure” for Covid-19.
“We want to emphasize that there is a cure. There is a solution that works 100%, “said Dr. Henry Ji, founder and CEO of Sorrento Therapeutics, to Fox News. “If we have the neutralizing antibody in your body, you don’t need social distancing. You can open a company without fear.”
Sorrento, actually, had not found the cure. Instead, the company had been running pre-clinical trials of coronavirus antibodies, an area where Regeneron (NASDAQ:REGN), AstraZeneca (NASDAQ:AZN), and other companies already had a long head start. (Regeneron, for instance, began clinical Phase 1/2/3 trials last June.)
Yet, investors understandably took Dr. Ji’s suggestions quite literally. The company is now facing at least two lawsuits for violating SEC Rule 10b-5 disclosures.
So Much for Learning From Mistakes
In July, Dr. Ji announced a $5 million licensing deal with Columbia University to develop a saliva-based Covid-19 test. Shares spiked to $18 as investors rushed in. And again, Sorrento disappointed.
“It’s a complete joke,” a senior administrator at Columbia said about the deal. “Why would we sell something for 5 million and royalties that has market potential? … This is nothing novel and the commercialization requirements will take time.”
And a joke it was. In August, rival Abbott Laboratories (NYSE:ABT) received FDA approval for its commercially viable rapid Covid-19 test. (Yale also received FDA approval for its saliva test). SRNE stock sank 65% over the following month.
Pumping Share Prices
Investors should quickly spot a pattern. In September, Sorrento once again announced an “agreement,” this time with the Mayo Clinic. In exchange for exclusive rights to Mayo’s ADNIC platform, “a potential breakthrough technology platform,” Sorrento would give the non-profit a $9.3 million upfront fee (mostly in shares) and $5.4 million in development costs.
Skeptical investors might wonder what’s going on? Why would the Mayo Clinic give away “breakthrough” technology for so little money? It smacks of the Columbia University testing-kit deal.
That’s because it is.
What’s Wrong With the Mayo Clinic Deal?
Readers would know by now that I always say this: know your investments.
And biotech is no different.
Here’s how antibody-based cancer treatments work: usually, cancerous cells grow because the human immune system fails to target them. So, researchers have developed lab-grown antibodies that 1) get injected into patients, 2) bind to cancer cells and 3) trigger the patient’s immune response to kill the tagged cells. There’s also a more advanced version, where the lab-grown antibodies are bound to a toxin that directly kills cancerous cells (known as ADC). It’s a simple process once you break it down, even if the research and production methods are highly complex.
Mayo Clinic is looking to create a new way to link antibodies (cancer-seekers) with toxins (cancer-killers) using nanoparticles, a method that “potentially addresses limitations of current ADC technology,” according to Sorrento.

So, What’s the Problem?
There are three critical problems with Sorrento’s plans. Firstly, the nanoparticles are expensive. Sorrento cites the cost of goods (COGS) as a reason why the new ADNIC technology could succeed, but I give that a diminishingly low chance. I imagine that’s also what researchers at the Mayo Clinic believed when licensing ADNIC out for the biotech equivalent of “peanuts.”
Secondly, the ADNIC platform doesn’t appear to work yet. There’s no mention of an effective test-case in the entire Sorrento press release. Presumably, the biotech firm plans to test its G-MAB antibody library against the ADNIC technology. But since none of their antibodies have yet shown efficacy with the old ADC technology, it’s the equivalent of throwing day-old spaghetti at the wall and hoping something sticks.
Most importantly, Sorrento’s $5.2 million pledge to the Mayo Clinic won’t even begin to cover ADNIC development (let alone the costs of a single drug). According to a review by the U.S. Department of Health & Human Services (HHS), drug companies spend $59.9 million in 2005 dollars (or $79.7 million today) in pre-clinical trials alone. And Phase 1/2/3 trials can then cost anywhere from $20 million to $67 million, according to the National Institutes of Health (NIH).
Could Sorrento stumble upon the next generation of cancer drugs? Of course. But an investor could also win the lottery by buying a ticket. And that’s not a sound investment strategy.
Sorrento’s Misaligned Incentives
Why would Sorrento management keep pouring money into tiny $5 million deals with so little chance of success? It’s a case of CEO pay at its worst.
In September, Sorrento released its annual proxy statement that outlined an absurd compensation structure for its Chairman/CEO, Dr. Ji. In exchange for reaching market capitalization “tranches,” Dr. Ji would receive up to 10% of all outstanding company shares.
Tesla (NASDAQ:TSLA) offered a similar compensation structure to CEO Elon Musk in 2018, but with two limitations:
Operational milestones. Tesla included revenue and adjusted EBITDA targets to the tranches, “designed to ensure that as Tesla’s market cap grows, the company is also executing well on both a top-line and bottom-line basis.”
Sole compensation. Elon Musk earns no salary or other stock options besides the tranche system.
On the other hand, Dr. Ji earned $8.1 million in 2019 from salary and options in addition to receiving his new “tranche” compensation. And the lack of operational milestones incentivizes management to push up share price with little regard for operational effectiveness.
No wonder they’re gambling with other people’s money.
What’s SRNE Stock Worth?
Investors will quickly realize that Sorrento has little value outside its only product, a lidocaine patch named ZTlido. The $21 million generated from ZTlido barely made a dent in Sorrento’s $182 million in R&D spend and $103 million in sales and general expenses. It’s preliminary third-quarter growth of 26% to $7.2 million is impressive … but it’s not enough.
And its cash position looks more like a failing retailer than a hot biotech startup. With just $24 million in the bank, the company barely has enough money for four months of R&D expenses. (It’s no surprise that Sorrento offered shares instead of cash for the $9.3 million upfront payment for ADNIC).
The median biotech company, on the other hand, carries 2.6 years of cash relative to R&D, according to Gurufocus, a financial data company. Similar sized companies to Sorrento hold an average of $440 million in liquidity.
So, why buy SRNE stock? Its shares could still surprise to the upside: make enough $5 million long-shot bets, and one might eventually pan out.
But will they? History says, “no.” No matter how good your corporate spin doctors are, remember this: your biotech investments are only worth the products they develop. And in Sorrento’s case, they’ve been spending more money enriching themselves and playing the biotech lottery than developing workable oncology drugs. Investors beware. Sorrento will keep gambling with your money if you give them a chance.
On the date of publication, Tom Yeung did not have (either directly or indirectly) any positions in the securities mentioned in this article.
Tom Yeung, CFA, is a registered investment advisor on a mission to bring simplicity to the world of investing.
More From InvestorPlace

Why Everyone Is Investing in 5G All WRONG

America’s #1 Stock Picker Reveals His Next 1,000% Winner

Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company

Could Tiny “Super” Battery Kill Big Tech?

The post Sorrento Stock Investors Should Play Powerball Instead appeared first on InvestorPlace.

* Benzinga has examined the prospects for many investor favorite stocks over the past week. * The FAANG stocks were represented in both the bullish and bearish calls seen this past week. * Other bullish calls were for some stocks found in struggling industries and sectors. The big three U.S. equity indexes ended last week solidly higher, led by the more than 4% gain in the Nasdaq. This came despite continuing volatility, due in part to presidential tweets in the wake of his treatment for COVID-19. The week also saw the vice presidential debate, as well as news that an alleged domestic terrorism plot apparently was foiled.Furthermore, an old-school conglomerate, a top bank and a video streaming leader all faced some bad news in the past week. Also, the iPhone maker confirmed the date of its next big event, and one equity index is rumored to be looking for a new home.Through it all, Benzinga continued to examine the prospects for many of the stocks that are most popular with investors. Here are a few of this past week’s most bullish and bearish posts that may be worth another look. Bulls The tech rally may have hit a recent speed bump, but Apple Inc. (NASDAQ: AAPL) and other big tech stocks are poised for another move higher, according to Shanthi Rexaline’sWhy This Wedbush Analyst Expects A Year-End Tech Rally.”In “Tesla Remains ‘Misvalued,’ Says SPAC King Palihapitiya,” Neer Varshney is focused on how the Tesla Inc (NASDAQ: TSLA) company may be misunderstood and underestimated by analysts and investors. See why the increasingly crowded electric vehicle space is not a concern.Why Barclays Is Turning Bullish On 4 Retailers” by Jayson Derrick discusses one top analyst upgraded American Eagle Outfitters Inc. (NYSE: AEO) and some other mall retailers after a decade of bearishness. Is the positivity warranted?”BofA Upgrades US Bancorp On Headwinds Giving Way To Tailwindsby Priya Nigam reveals why recent activity could be signaling a strong rebound for US Bancorp (NYSE: USB) stock for the rest of the year.In Wayne Duggan’sGoldman Sachs Calls General Electric The ‘Ultimate Self-Help, Vaccine Leverage Story’,” see why General Electric Co. (NYSE: GIVE) could emerge even an stronger company in a post-pandemic economy.For additional bullish calls seen in the past week, also have a look at these posts: * 3 Tech Stocks In Berkshire Hathaway’s Portfolio * Which EV Stock Will Grow The Most By 2025? * Square Invests M In Bitcoin; Dorsey Sees A Currency For The Internet Bears “Facebook, Amazon, Apple, Google Stamping Out Rivals, Stifling Innovation, House Antitrust Investigation Concludesby Shivdeep Dhaliwal shows what a congressional panel has concluded about Amazon.com Inc. (NASDAQ: AMZN) and other tech giants.After stellar performances in the first half of the year, expectations for Netflix Inc. (NASDAQ: NFLX) are muted for the third quarter. So says “7 Worrisome Metrics That Underscore Risks To Netflix’s Q3 Results” by Shanthi Rexaline.In Priya Nigam’s “KeyBanc Turns Bearish On AT&T, Says Consumers Facing Macro Pressure,” see how AT&T Inc. (NYSE: T) may be “secularly and competitively challenged” despite high expectations.Wayne Duggan’s “Analyst: Cruise Industry On Life Support Heading Into Q4” shows why there appears to be little hope for improvement anytime soon for Carnival Corp. (NYSE: CCL) and its peers in the industry.Todd Shriber’s “Big Financial ETF Tagged With ‘Speculative’ Rating” discusses how historically low interest rates and rising loan loss reserves have dragged on the Financial Select Sector SPDR (NYSEARCA: XLF).Be sure to check out Lloyd Blankfein Blames SPACs, Free Money For Bubble Territory and Fed Chair Powell On Economic Recovery: ‘Still A Long Way To Gofor additional bearish calls from the past week.At the time of this writing, the author had no position in the mentioned equities.Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Notable Insider Buys Last Week: Blackstone, CarMax And More * Barron’s Picks And Pans: Albemarle, Camping World, Terex And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Artificial intelligence is set to be a massive trend in the coming decades. As such, investors are looking to find companies that can profit from the trend. But for several reasons, finding quality AI stocks is harder than it might seem.
First, some of the leaders in artificial intelligence are massive businesses, which means AI simply isn’t big enough. Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) and China’s Baidu (NASDAQ:BIDU), for instance, have invested heavily in artificial intelligence through both research and development spending and acquisitions. They qualify as legitimate AI stocks.
But what about, say, Microsoft (NASDAQ:MSFT)? Its Azure cloud platform offers machine learning, and AI is a feature of many other products. But the bulk of Microsoft’s business is based on more traditional software (and hardware) offerings. Given a $1.6 trillion market capitalization, it’s difficult to argue that AI, in and of itself, should or even could move MSFT stock higher.InvestorPlace – Stock Market News, Stock Advice & Trading Tips
The second issue is that individual artificial intelligence efforts themselves have vastly different importance. For Alphabet, AI efforts range from spending billions to develop fully autonomous driving to offering text suggestions in Gmail. Success (or failure) with self-driving cars can move GOOG stock. Gmail adoption simply doesn’t have the same effect.
Indeed, some form of artificial intelligence is a must for essentially every major company in the world. That doesn’t mean that they’re all AI plays. Most artificial intelligence efforts at this point qualify more as improvements on existing products rather than new lines of business.

9 Gaming Stocks That Won’t Hit ‘Game Over’ Anytime Soon

So investors looking to play artificial intelligence need to make sure that they’re actually gaining exposure to the trend. These seven stocks often are thought of as AI stocks, but upon closer inspection for various reasons, they don’t actually qualify:
IBM (NYSE:IBM)
PROS Holdings (NYSE:PRO)
Intel (NASDAQ:INTC)
Ambarella (NASDAQ:AMBA)
Remark Holdings (NASDAQ:MARK)
Veritone (NASDAQ:VERI)
Palantir Technologies (NYSE:PLTR)

AI Stocks With Too Much Hype: IBM (IBM)
Source: Laborant / Shutterstock.com

As far as AI stocks go, IBM might have been the first. But it’s been far from the best.
Back in 1997, IBM first brought artificial intelligence into the mainstream. Its Deep Blue supercomputer beat the world champion at chess. IBM seemed poised to lead the AI revolution, which seemingly made IBM stock a sure bet.
For a time, it was. The stock soared in the late 1990s amid the dot-com boom (and then bubble). Over the 15 years after Deep Blue won, IBM stock gained 380%. The Nasdaq Composite rose just 120% over the same stretch.
In recent years, however, IBM stock has struggled. And its AI efforts are a reason why. The company’s Watson offerings haven’t been successful enough. IBM infamously saw revenue decline for 22 consecutive quarters. Legacy businesses like mainframes drove the decline, but AI growth disappointed as well.
As a result, IBM stock is headed in the wrong direction. Over the last eight years, it has lost 41% of its value. The Nasdaq has rallied 262%.
And it’s tough to see Watson and other AI efforts reversing that trend. Efforts to apply the technology to healthcare, in particular, haven’t worked out. Despite billions of dollars in investments and acquisitions, at least one former IBM employee has said that IBM no longer is “on the cutting edge.” Investors looking for AI stocks to buy probably should stick with those companies that are.

PROS Holdings (PRO)
Source: Shutterstock

PROS Holdings clearly belongs on any list of AI stocks, as it’s actually a direct provider of artificial intelligence solutions. Solutions provided by PROS help e-commerce companies price their goods, and airlines estimate customer demand — all in real time.
So for investors taking the long view, PRO stock does look intriguing. But there are two big concerns.
The first is that PROS is facing a significant amount of pressure from the novel coronavirus pandemic. Airlines are key customers, a key reason why the stock is down 44% so far this year. It will take some time for that industry to bounce back — and to stop seeing PROS products as a luxury amid a spate of cost-cutting.
The second concern is that PROS isn’t profitable. The pandemic isn’t solely to blame. The company lost money in 2019, even on an EBITDA (earnings before interest, taxes, depreciation and amortization) basis. That financial profile seems to cast doubt on the strength of the product offering.
That’s not a death knell for a company with a big long-term opportunity. But PROS isn’t a relatively new growth stock. It was founded in 1985.

10 Best ETFs for 2020: The Battle At the Top Tightens

The product offering and the opportunity both admittedly are intriguing. At some point, however, even the fastest-growing AI company needs to make money. PROS, so far, hasn’t proven that it can, and with customers struggling, PRO stock may not rally until it can do so.

Intel (INTC)
Source: Sundry Photography / Shutterstock.com

One place to look for AI plays is in the semiconductor sector. Artificial intelligence and machine learning will require ever-larger amounts of computing power. The chip companies that can deliver the processors behind that power stand to make substantial profits.
The problem for Intel stock, however, is that the company hasn’t shown that it can become one of the sector’s winners. Years of development delays left the company behind at the 10 nanometer node. It’s now struggling to get to 7nm, while rivals are heading to 3nm.
INTC stock admittedly is cheap after it plunged following Q2 earnings. But it was the disclosure of yet another delay that drove the plunge. Meanwhile, investors in AI stocks aren’t looking for “cheap.” They’re looking for growth. Intel is not going to provide that growth unless it can deliver the processors needed to power AI applications. Right now, that seems unlikely.

Ambarella (AMBA)
Source: Sundry Photography / Shutterstock.com

In the beginning of the year, Ambarella looked to position itself as an artificial intelligence play. The developer of semiconductors for video applications has been trying for years to pivot away from its reliance on GoPro (NASDAQ:GPRO). That relationship sent AMBA stock past $120 back in 2015, but has left the stock “dead money” in the five years since.
There is some reason for optimism. Ambarella spent over $300 million developing its architecture. A partnership with Amazon (NASDAQ:AMZN) allows developers to run machine learning applications on any device with an Ambarella SoC (system-on-a-chip). Ambarella’s experience with video processing makes it a potential winner from AI applications in security cameras and, eventually, autonomous vehicles.
But the move into AI is fraught with risk as well. Ambarella hardly has any of those markets to itself; competition will be fierce, particularly in AVs. Ambarella’s revenue had stagnated even before the pandemic, and GoPro is not the only reason why.

The 7 Best Growth Stocks To Buy For Less Than$1000

More broadly, so-called “pivots” in tech in recent years haven’t worked out well. Market leaders generally have too much capital, and too much freedom to aggressively invest that capital instead of focusing on short-term profits. Ambarella might be able to crack the code, but despite management’s claims, this seems like a “show me story” as far as its AI ambitions go.

Remark Holdings (MARK)
Source: Angyalosi Beata / Shutterstock.com

Remark is another “show me” story, albeit one with a less-impressive past. The company has been trying to push its AI ambitions for some time, while also operating an online medical advice platform and an e-commerce business that sells bikinis.
The three businesses have had little success. In 2019, Remark generated revenue of $5 million, and an Adjusted EBITDA loss of nearly $27 million. Remark seemed to be on a path toward bankruptcy at the beginning of this year, and by April MARK stock traded below 50 cents.
But the pandemic gave the company an opportunity. Remark now offers AI-powered thermal imaging cameras to detect symptoms of Covid-19. The optimism toward that offering sent MARK stock soaring 600% in barely a month this spring. Remark took advantage of the spike to sell stock and fix its balance sheet, at least for the time being.
On this site in August, Luke Lango argued that the Covid-19 opportunity made MARK stock a potential winner, if admittedly a high-risk choice. I’m a bit more skeptical.
Remark hasn’t really delivered much in the way of major orders, with just $1.1 million in second quarter revenue attributed to the efforts. Research and development spending for the entire first half was just $2.1 million, which hardly seems like enough to develop a market-leading platform.
Given that Remark has a market capitalization of just $120 million, Lango is correct that the rewards if Remark succeeds are potentially huge. That seems like an enormous “if,” however.

Veritone (VERI)
Source: Shutterstock

Veritone has positioned itself as one of the leading AI stocks. The company claims that its aiWARE solution is “the world’s first operating system for artificial intelligence.”
It’s heady stuff. But the claims are belied by the company’s fundamentals. Growth has been meager, even before the pandemic. Surely, an AI OS would be a massive opportunity, yet research and development spending declined 43% year-over-year in the first six months of 2020.
Meanwhile, Veritone isn’t even predominantly an AI play yet. Less than a quarter of first-half sales came from aiWARE (a total of just $6.1 million); more than half came from its full-service advertising business.

7 Innovative Stocks That Will Disrupt Their Sectors

It’s possible Veritone’s plans work out. But with VERI stock up 314% year-to-date on the back of AI optimism, they better.

Palantir Technologies (PLTR)
Source: Sundry Photography / Shutterstock.com

Investors waited for years for Palantir to go public. Now that it is, they don’t seem very enthused.
Palantir opened on the New York Stock Exchange at $10 on Sept. 30. It closed at $10 on Wednesday. In this market, the lack of an IPO “pop” should be a concern.
It probably is. Palantir has positioned itself as a “big data” company that focuses on the U.S. intelligence and law enforcement communities. Its software supposedly allows analysts, with the help of AI, to find patterns in the vast amounts of data collected.
But as New York magazine noted in an intriguing profile, Palantir’s offerings remain hugely labor-intensive. Part of that comes from the classic “garbage in, garbage out” problem: AI and machine learning aren’t effective if the data is inaccurate, as can often be the case. But whatever the cause, Palantir’s AI solutions aren’t quite the “magic bullet” observers believed they might be.
Indeed, Palantir’s fundamentals highlight the risk. Gross margins are below 70% — low for a software company. Operating loss last year was $576 million, more than 77% of revenue. (To be fair, margins improved substantially in the first half of this year.)
The risk to PLTR stock is that long-term margins aren’t going to be what its business model might suggest. Soft early trading in a market that has bid up the majority of IPOs suggest that plenty of investors see that risk as all too real.
On the date of publication, Vince Martin did not have (either directly or indirectly) any positions in the securities mentioned in this article.
After spending time at a retail brokerage, Vince Martin has covered the financial industry for close to a decade for InvestorPlace.com and other outlets.
More From InvestorPlace

Why Everyone Is Investing in 5G All WRONG

America’s #1 Stock Picker Reveals His Next 1,000% Winner

Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company

Could Tiny “Super” Battery Kill Big Tech?

The post 7 AI Stocks With More Hype Than Bite appeared first on InvestorPlace.

Source: https://finance.yahoo.com/news/prime-day-smart-home-security-084000698.html

Ring, Google Nest, Home automation, Wireless security camera, Blink Home, Amazon.com, Amazon Prime

World news – US – Prime Day Smart Home & Security Camera Deals (2020): Best Early Ring, Blink, Nest, Arlo & Philips Hue Savings Tracked by Deal Stripe

Building on its expertise in the areas of digital, technologies and processes , CSS Engineering you in your most ambitious transformation projects and helps you bring out new ideas, new offers, new modes of collaboration, new ways of producing and selling.

CSS Engineering is involved in projects each customer as if it were his own. We believe a consulting company should be more than an advisor. We put ourselves in the place of our customers, to align we incentives to their goals, and collaborate to unlock the full potential their business. This establishes deep relationships and enjoyable.

Our services:

  1. Create professional websites
  2. Hosting high performance and unlimited
  3. Sale and video surveillance cameras installation
  4. Sale and Installation of security system and alarm
  5. E-Marketing

All our achievements here https://www.css-engineering.com/en/works/

LEAVE A REPLY

Please enter your comment!
Please enter your name here